Expression of high‐abundance proteins in sera of patients with endometrial and cervical cancers: Analysis using 2‐DE with silver staining and lectin detection methods
Authors:
- 18 June 2007
- journal article
- proteomics and-2-de
- Published by Wiley in Electrophoresis
- Vol. 28 (12) , 1989-1996
Abstract
The expression of high‐abundance serum proteins in newly diagnosed patients with endometrial adenocarcinoma (EACa), squamous cell cervical carcinoma (SCCa) and cervical adenocarcinoma (ACCa), relative to control female subjects, was analyzed by subjecting serum samples to 2‐DE followed by image analysis of the silver‐stained protein profiles. The three cohorts of cancer patients demonstrated different altered expression of serum high‐abundance proteins compared to negative control women. The expression of α1‐antitrypsin, α1‐B glycoprotein, cleaved high‐molecular‐weight kininogen (light chain) and antithrombin III were consistently altered in all the patients. However, clusterin was upregulated only in the patients with EACa, while those with SCCa and ACCa were typically characterized by the upregulated expression of zinc α‐2‐glycoprotein. The aberrant expression of selective serum proteins in the various cohorts of cancer patients was validated by competitive ELISA as well as by lectin detection. Analysis by using the champedak galactose binding lectin further highlighted an unidentified protein that may be differently glycosylated in the sera of the EACa patients that were studied.Keywords
This publication has 31 references indexed in Scilit:
- Patients with congenital hypothyroidism demonstrate different altered expression of plasma fibrinogen and haptoglobin polypeptide chainsClinical Biochemistry, 2006
- Aberrant expression of acute‐phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumorsElectrophoresis, 2004
- Tissue and serum CA125 expression in endometrial cancerInternational Journal of Gynecological Cancer, 2002
- Proteomic Approaches within the NCI Early Detection Research Network for the Discovery and Identification of Cancer BiomarkersAnnals of the New York Academy of Sciences, 2001
- Prothrombin Fragment F1+2 and Thrombin–Antithrombin III Complex (TAT) Plasma Levels in Patients with Gynecological CancerGynecologic Oncology, 1996
- Tumor Antigens CA 19.9, CA 125, and CEA in Carcinoma of the Uterine CervixGynecologic Oncology, 1995
- Inside SWISS‐2DPAGE databaseElectrophoresis, 1995
- Iga binding lectins isolated from distinct artocarpus species demonstrate differential specificityMolecular Immunology, 1991
- Zinc alpha-2 glycoprotein levels in serum and breast fluids: a potential marker of apocrine activityEuropean Journal of Cancer and Clinical Oncology, 1991
- Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gelsElectrophoresis, 1988